AVALON GLOBOCARE CORP (AVCO)

US05344R1041 - Common Stock

0.5259  -0.1 (-16.52%)

After market: 0.601 +0.08 (+14.28%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to AVCO. AVCO was compared to 66 industry peers in the Real Estate Management & Development industry. Both the profitability and financial health of AVCO have multiple concerns. AVCO does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

AVCO had negative earnings in the past year.
In the past year AVCO has reported a negative cash flow from operations.
In the past 5 years AVCO always reported negative net income.
In the past 5 years AVCO always reported negative operating cash flow.

1.2 Ratios

Industry RankSector Rank
ROA -82.31%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -556.86%
PM -600.07%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

AVCO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AVCO has more shares outstanding
The number of shares outstanding for AVCO has been increased compared to 5 years ago.
AVCO has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -7.78, we must say that AVCO is in the distress zone and has some risk of bankruptcy.
AVCO has a Debt/Equity ratio of 14.00. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 14
Debt/FCF N/A
Altman-Z -7.78
ROIC/WACCN/A
WACC8.18%

2.3 Liquidity

AVCO has a Current Ratio of 0.23. This is a bad value and indicates that AVCO is not financially healthy enough and could expect problems in meeting its short term obligations.
AVCO has a Quick Ratio of 0.23. This is a bad value and indicates that AVCO is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.23

2

3. Growth

3.1 Past

AVCO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.93%, which is quite impressive.
The Revenue has been growing slightly by 5.16% in the past year.
The Revenue has been growing by 17.67% on average over the past years. This is quite good.
EPS 1Y27.93%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q18.38%
Revenue growth 1Y5.16%
Revenue growth 3Y-3.8%
Revenue growth 5Y17.67%
Revenue growth Q2Q3.78%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AVCO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -6.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AVCO!.
Industry RankSector Rank
Dividend Yield N/A

AVALON GLOBOCARE CORP

NASDAQ:AVCO (11/9/2022, 7:00:00 PM)

After market: 0.601 +0.08 (+14.28%)

0.5259

-0.1 (-16.52%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)08-15 2022-08-15
Earnings (Next)11-22 2022-11-22/amc
Inst OwnersN/A
Inst Owner Change-100%
Ins OwnersN/A
Ins Owner Change0%
Market Cap46.82M
Analysts0
Price TargetN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 33.22
P/FCF N/A
P/OCF N/A
P/B 268.62
P/tB 268.32
EV/EBITDA -6.4
EPS(TTM)-0.1
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.02
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -82.31%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -556.86%
PM -600.07%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.68%
Cap/Sales N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.23
Altman-Z -7.78
F-Score4
WACC8.18%
ROIC/WACCN/A
Cap/Depr(3y)40.65%
Cap/Depr(5y)947.47%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y27.93%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q18.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue growth 1Y5.16%
Revenue growth 3Y-3.8%
Revenue growth 5Y17.67%
Revenue growth Q2Q3.78%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y27.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y29.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.72%
OCF growth 3YN/A
OCF growth 5YN/A